Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,454 | 530 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,604 | 83 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,045 | 44 | $0 (2024) |
| Lilly USA, LLC | $983.91 | 55 | $0 (2024) |
| GlaxoSmithKline, LLC. | $971.78 | 51 | $0 (2024) |
| ABBVIE INC. | $834.81 | 43 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $779.50 | 34 | $0 (2024) |
| PFIZER INC. | $594.66 | 39 | $0 (2024) |
| Abbott Laboratories | $517.79 | 29 | $0 (2024) |
| Amgen Inc. | $354.17 | 14 | $0 (2024) |
| Rigel Pharmaceuticals, Inc. | $309.38 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,217 | 163 | AstraZeneca Pharmaceuticals LP ($513.63) |
| 2023 | $2,684 | 141 | Novo Nordisk Inc ($497.53) |
| 2022 | $2,825 | 134 | Novo Nordisk Inc ($430.82) |
| 2021 | $1,728 | 92 | Boehringer Ingelheim Pharmaceuticals, Inc. ($258.97) |
All Payment Transactions
530 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: Oncology | ||||||
| 12/20/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Hematology | ||||||
| 12/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.00 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Oncology | ||||||
| 12/09/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: VACCINES | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $31.26 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $25.22 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 11/25/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $20.87 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 11/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $3.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.20 | General |
| 10/21/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 142 | 177 | $39,363 | $14,357 |
| 2022 | 3 | 155 | 223 | $49,137 | $17,611 |
| 2021 | 4 | 199 | 239 | $50,533 | $19,074 |
| 2020 | 4 | 212 | 241 | $45,409 | $13,742 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 100 | $22,400 | $7,095 | 31.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 58 | 58 | $14,094 | $6,472 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 19 | $2,869 | $789.97 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 140 | $31,360 | $9,603 | 30.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 57 | 57 | $13,851 | $6,430 | 46.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 26 | $3,926 | $1,578 | 40.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 69 | 69 | $16,767 | $7,973 | 47.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 71 | 102 | $22,848 | $6,996 | 30.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 42 | $6,342 | $2,243 | 35.4% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 26 | 26 | $4,576 | $1,863 | 40.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 63 | 63 | $15,309 | $6,268 | 40.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 57 | 72 | $16,128 | $4,072 | 25.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 74 | 88 | $13,288 | $3,126 | 23.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 18 | 18 | $684.00 | $275.92 | 40.3% |
About David Ramos, APRN
David Ramos, APRN is a Family healthcare provider based in Riverside, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2010. The National Provider Identifier (NPI) number assigned to this provider is 1114227436.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Ramos, APRN has received a total of $10,454 in payments from pharmaceutical and medical device companies, with $3,217 received in 2024. These payments were reported across 530 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($10,454).
As a Medicare-enrolled provider, Ramos has provided services to 708 Medicare beneficiaries, totaling 880 services with total Medicare billing of $64,785. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Riverside, RI
- Active Since 11/03/2010
- Last Updated 09/25/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1114227436
Products in Payments
- TRELEGY ELLIPTA (Drug) $799.77
- Ozempic (Drug) $709.20
- JARDIANCE (Drug) $697.74
- Rybelsus (Drug) $531.54
- BREZTRI (Drug) $438.48
- UBRELVY (Drug) $358.71
- MOUNJARO (Drug) $342.35
- Rezlidhia (Drug) $309.38
- FREESTYLE LIBRE 3 (Device) $304.11
- ELIQUIS (Drug) $274.96
- AIRSUPRA (Drug) $272.98
- FARXIGA (Drug) $267.05
- Wegovy (Drug) $246.05
- VRAYLAR (Drug) $238.39
- STIOLTO RESPIMAT (Drug) $229.06
- XPOVIO (Drug) $201.15
- XARELTO (Drug) $197.05
- Cologuard Collection Kit (Device) $183.47
- Yupelri (Drug) $179.80
- AREXVY (Drug) $172.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Riverside
Michael Josiah
Family — Payments: $6,456
Ms. Keena Harrison, Fnp-C, FNP-C
Family — Payments: $5,383
Nicole De Angelis
Family — Payments: $4,895
Mrs. Catherine Luz, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C
Family — Payments: $4,333
Ms. Mayra Rivera, Fnp, FNP
Family — Payments: $4,018
Hannah Vance, Msn, Fnp-C, MSN, FNP-C
Family — Payments: $3,245